labiotech22 小时
Seven miRNA-focused companies pioneering new therapies in 2024
Delve into the field of miRNA with 7 promising companies with miRNA-focused candidates in the pipeline, from oncology to neurodegeneration.
Ensysce Biosciences Inc.: Ensysce Biosciences Completes Significant Milestone, Dosing First ...
Landmark Overdose Protection Clinical Trial of PF614-MPAR ~~ Expects Early Interim Data in 1Q 2025 ~ SAN DIEGO, CA / ACCESSWIRE / November 26, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" ...